Journal of the Korean Ophthalmological Society 2006;47(8):1238-1243.
Published online August 31, 2006.
The Risk Factors for Severe Thyroid-Associated Orbitopathy.
Jong Keun Chae, Byoung Jin Kim, Michael Kazim
1Department of Ophthalmology, Kangdong Sacred Heart Hospital, Hallym University, College of Medicine, Seoul, Korea. feeloph@naver.com
2Department of Ophthalmology, New York Presbyterian Hospital, Columbia University, College of Physicians and Surgeons, New York, U.S.A.
심한 갑상샘연관안와병증과 연관된 위험인자
채종근1,김병진1,Michael Kazim2
Department of Ophthalmology, Kangdong Sacred Heart Hospital, Hallym University, College of Medicine1, Seoul, Korea Department of Ophthalmology, New York Presbyterian Hospital, Columbia University, College of Physicians and Surgeons2, New York, U.S.A.
Correspondence:  Jong Keun Chae, M.D.1
Abstract
PURPOSE
To determine risk factors for severe Thyroid-Associated Orbitopathy (TAO). METHODS: We retrospectively studied the clinical data of 385 patients of the New York City area diagnosed with TAO from January 1990 to December 2000. We reviewed clinical characteristics and tried to identify several risk factors. The statistical analysis was applied to the collected data. RESULTS: Men more frequently had proptosis, restrictive myopathy, and optic neuropathy than women. Patients older than 50 years presented more frequently with proptosis, restrictive myopathy, and optic neuropathy than younger than 50 years. Patients with a family history of thyroid disease had similar clinical characteristics compare to those without family history. Smokers more often had proptosis, restrictive myopathy, and compressive optic neuropathy than nonsmokers. Patients who had received radioactive iodine (RAI) treatment were older, and were more frequently smokers. If patients were smokers and treated with radioactive iodine treatment, they were more likely to have proptosis, restrictive myopathy, and compressive optic neuropathy than if not treated with radioactive iodine. However, the RAI treatment did not seem to be associated with severe characteristics of TAO in non-smokers. CONCLUSIONS: The risk factors for severe TAO are: male, age older than 50, smoking, treated with RAI in smokers.
Key Words: Risk factor;Thyroid-associated orbitopathy (TAO);New york city


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next